Fast Shipping Kiravia Blue 520™ Anti-human P2ry12 Series [9lRxMJf6]

KIRAVIA Blue 520™ Anti-Human P2RY12

The Fast Shipping Kiravia Blue 520™ Anti-human P2ry12 Series [9lRxMJf6] is a cutting-edge monoclonal antibody designed for research applications in the field of hematology and immunology. This antibody targets the P2RY12 receptor, which plays a crucial role in platelet aggregation and blood coagulation. With its high specificity and affinity, it offers a powerful tool for studying thromboembolisms and other clotting disorders.

• High specificity for P2RY12 receptor
• Key target for platelet aggregation research

Product Features and Specifications

The Fast Shipping Kiravia Blue 520™ Anti-human P2ry12 Series [9lRxMJf6] is produced through a mouse monoclonal technology, ensuring consistent and reliable results. This antibody is conjugated with KIRAVIA Blue 520™, a near-infrared dye that provides enhanced fluorescence and reduced background noise in flow cytometry experiments. It is formatted as a monoclonal antibody, making it suitable for various applications, including fluorescence-activated cell sorting (FACS) and immunofluorescence (IF).

• Monoclonal antibody technology for consistent results
• Conjugated with KIRAVIA Blue 520™ for improved fluorescence
• Format suitable for FACS and IF applications

Practical Uses and Benefits

The Fast Shipping Kiravia Blue 520™ Anti-human P2ry12 Series [9lRxMJf6] is a valuable reagent for researchers investigating the role of P2RY12 in platelet aggregation and blood coagulation. Its expression on various tissues, including platelets, lung, appendix, pituitary, and adrenal glands, makes it a versatile tool for identifying microglial cells in the brain. This antibody is also highly beneficial for studying thromboembolisms and other clotting disorders, offering a promising approach for therapeutic intervention.

• Expression on multiple tissues for versatile applications
• Useful for identifying microglial cells in the brain
• Promising for studying thromboembolisms and clotting disorders